medigraphic.com
SPANISH

MediSur

ISSN 1727-897X (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2015, Number 2

<< Back Next >>

Medisur 2015; 13 (2)

Monostotic fibrous dysplasia in the humerus. Case report

Morejón TY, Ferrer LY, Díaz PD
Full text How to cite this article

Language: Spanish
References: 9
Page: 326-332
PDF size: 242.45 Kb.


Key words:

fibrous dysplasia, monostotic, humerus, case reports.

ABSTRACT

The fibrous Dysplasia is a metabolic osseous disease characterized by an accelerated osseous reabsorption, followed by the formation of an osseous womb incremented and disorganized of uncertain origin. The most frequent clinical manifestation is the continuous pain at the damaged zone. It is diagnosed for the clinic, radiological studies and the use of biochemical scoreboards. It is treated with bisphosphonates, indicated in cases with clinical manifestations and in those without symptoms in the ones that evidence areas of activity. A patient with a background of posttraumatic pain in the right elbow of a month of evolution unanswered to the treatment, he was diagnosed in the X-ray picture of third distal part of straight humerus, lithic injuries, without rupture of the cortical, with marked periostatic reaction, without radiological or ganmagraphic findings of lesion to other levels. The value of the alkaline phosphates in 1790 mmol/l corroborated the diagnosis of monostotic fibrous dysplasia in the humerus. The appropriate presentation was decided for the uncommon of this localization.


REFERENCES

  1. Morissette J, Laurin N, Brown J. Sequestosome 1: Mutation frequencies, haplotypes and phenotypes in familial Paget´s disease of bone. J Bone Miner Res. 2006;21 Suppl 2:38-44

  2. Josse R, Hanley D, Kendler D, Ste Marie LG, Adachi J, Brown J. Diagnosis and treatment of Paget´s disease of bone. Clin Invest Med. 2007;30(5):E210-23

  3. Reddy SV. Etiology of Paget disease and osteoclast abnormalities. J Cel Biochem. 2004;93(4):688-96

  4. Hernández C, Villanueva M, Ríos A, Benito F, Castelorio R. Enfermedad de Paget monostótica rotuliana. Act Ortop Méx. 2010;24(1):14-7

  5. Roodman G, Windle J. Paget disease of bone. J Clin Invest. 2005;115(2):200-8

  6. González G, Brusco F, Arteaga E, Rodríguez J, Jacobelli S, Massardo L, et al. Enfermedad de Paget en Chile: una serie de 15 pacientes. Rev Méd Chile. 2003;131(5):491-7

  7. Ribera J. Epidemiología de la enfermedad osteoarticular en la persona mayor. JANO. 2003;64(1468):21-7

  8. Morris C, Einhorn T. Biphosphonates in orthopedic surgery. J Bone Joint Surg Am. 2005;87(7):1609-18

  9. Reszka A, Rodan G. Mechanism of action of biphosphonates. Curr Osteo Reports. 2003;1:45-52




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Medisur. 2015;13